403 Forbidden

Coagulation and Platelet Function Test Kit (Viscoelastic Assay)

For use in conjunction with coagulation and platelet function analyzers, this device can comprehensively detect the entire coagulation process. It can quickly identify coagulation issues in patients and promptly determine the risk of imminent bleeding or thrombosis.

Activated Clotting Time and Coagulation Rate Test Kit (Viscoelastic Assay)

For use in conjunction with coagulation and platelet function analyzers, this device can comprehensively detect the entire coagulation process. It can quickly identify coagulation issues in patients and promptly determine the risk of imminent bleeding or thrombosis. It is particularly suitable for heparinized blood samples (≥2 UI/mL).

Platelet Agonist,ADP

For use with a fully automated platelet function analyzer, this method involves adding the inducer adenosine diphosphate (ADP) to whole blood samples. By detecting the quantity and morphology of platelets under multiple conditions, the function of platelets can be assessed.

Platelet Agonist,AA

For use with a fully automated platelet function analyzer, this method involves adding the inducer arachidonic acid to whole blood samples. By detecting the quantity and morphology of platelets under multiple conditions, the function of platelets can be assessed.

Platelet Agonist,COL

For use with a fully automated platelet function analyzer, this method involves adding the inducer collagen to whole blood samples. By detecting the quantity and morphology of platelets under multiple conditions, the function of platelets can be assessed.

Platelet Agonist,EPI

For use with a fully automated platelet function analyzer, this method involves adding the inducer epinephrine to whole blood samples. By detecting the quantity and morphology of platelets under multiple conditions, the function of platelets can be assessed.

D-Dimer Assay Kit(CLIA)

Using chemiluminescent immunoassay, quantitatively detect the concentration of D-dimer in human plasma samples in vitro to assess primary or secondary hyperfibrinolysis.

Fibrin(-ogen) Degradation Products Assay Kit(CLIA)

Using chemiluminescent immunoassay, quantitatively detect the concentration of fibrin(fibrinogen) degradation products in human plasma samples in vitro to assess primary or secondary hyperfibrinolysis.

Thrombomodulin Assay Kit(CLIA)

Using chemiluminescent immunoassay, quantitatively detect the concentration of thrombomodulin in human plasma samples in vitro to assess endothelial cell damage.

Plasmin-α2-plasmin Inhibitor Complex Assay Kit(CLIA)

Using chemiluminescent immunoassay, quantitatively detect the concentration of plasmin-α2-plasmin inhibitor complex in human plasma samples in vitro to assess plasmin activation.